Abstract
Treatment of Erectile Dysfunction (ED) should be started with the elimination of correctable factors such as diabetes, cardiovascular causes, and drug use that cause ED, and lifestyle changes. Currently ED treatment mostly depends on phosphodiesterase type 5 inhibitors, which fail for some ED patients. Surgical and nonsurgical treatments in Peyronie’s disease related ED are frequently difficult to achieve satisfactory results. Recent studies indicate that extracorporeal shock wave therapy induces neoangiogenesis and positively affects on penile hemodynamics. In this review the evidence of clinical efficacy of extracorporeal shock wave therapy for the treatment of erectile dysfunction and Peyronie’s disease. Keywords: erectile dysfunction, Peyronie’s disease, extracorporeal shockwave therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
